Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Singular Genomics Systems, Inc. | 10%+ Owner | Common stock | 2.65M | $1.12M | $0.42 | Jun 1, 2021 | Direct |
Vigil Neuroscience, Inc. | 10%+ Owner | Common stock | 193K | $724K | $3.75 | Jan 11, 2022 | Direct |
Xilio Therapeutics, Inc. | 10%+ Owner | Common stock | 166K | $138K | $0.83 | Oct 26, 2021 | Direct |
Singular Genomics Systems, Inc. | 10%+ Owner | Series A convertible preferred stock | 0 | Jun 1, 2021 | Direct | ||
Singular Genomics Systems, Inc. | 10%+ Owner | Series B convertible preferred stock | 0 | Jun 1, 2021 | Direct | ||
Vigil Neuroscience, Inc. | 10%+ Owner | Series A convertible preferred stock | 0 | Jan 11, 2022 | Direct | ||
Vigil Neuroscience, Inc. | 10%+ Owner | Series B convertible preferred stock | 0 | Jan 11, 2022 | Direct | ||
Xilio Therapeutics, Inc. | 10%+ Owner | Series B convertible preferred stock | 0 | Oct 26, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VIGL | Vigil Neuroscience, Inc. | Jan 11, 2022 | 3 | $0 | 4 | Jan 11, 2022 | 10%+ Owner |
VIGL | Vigil Neuroscience, Inc. | Jan 6, 2022 | 0 | $0 | 3 | Jan 6, 2022 | 10%+ Owner |
XLO | Xilio Therapeutics, Inc. | Oct 26, 2021 | 2 | $0 | 4 | Oct 26, 2021 | 10%+ Owner |
XLO | Xilio Therapeutics, Inc. | Oct 21, 2021 | 0 | $0 | 3 | Oct 21, 2021 | 10%+ Owner |
OMIC | Singular Genomics Systems, Inc. | Jun 1, 2021 | 3 | $0 | 4 | Jun 1, 2021 | 10%+ Owner |
OMIC | Singular Genomics Systems, Inc. | May 26, 2021 | 0 | $0 | 3 | May 26, 2021 | 10%+ Owner |